Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
316K
-
Shares change
-
-6.12M
-
Total reported value, excl. options
-
$2.04M
-
Value change
-
-$39.6M
-
Number of sells
-
-9
-
Price
-
$6.47
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q4 2023
11 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q4 2023.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 316K shares
of 71.9M outstanding shares and own 0.44% of the company stock.
Largest 10 shareholders include Neumann Advisory Hong Kong Ltd (316K shares), Horizon Investments, LLC (52 shares), WELLS FARGO & COMPANY/MN (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares), GROUP ONE TRADING, L.P. (0 shares), STATE STREET CORP (0 shares), Vivo Capital, LLC (0 shares), UBS Group AG (0 shares), and JPMORGAN CHASE & CO (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.